Faculty collaboration in action - a sample selection
Imperial collaboration in action - a sample selection
The MRC Clinical Sciences Centre led 'Integrative Experimental Computational Biology Studentships' scheme is a new scheme recently established as part of integrative biology developments at the CSC. It aims to enhance the skill-base in computational and systems biology by promoting research collaborations that integrate wet and dry laboratory skills. The studentships will support innovative research programs that promote interactions with the Faculties of Natural Sciences and Engineering as well as other departments within the Faculty of Medicine - with co-supervision from the relevant Faculty.
Learn more about Faculty doctoral training and support schemes on our Postgraduate research pages
The MRC-PHE Centre for Environment and Health is a partnership between the College and King’s College London, funded by the MRC and Public Health England (PHE). The Centre also collaborates with St George’s University of London and London School of Hygiene and Tropical Medicine. The Centre investigates environmental health problems of key public health and scientific importance - utilising technologies and techniques such as geographical information systems (GIS), statistical modelling techniques, biomarker and mechanistic studies, to large population analyses.
MRC-PHE Centre for Environment and Health
Learn more about other Faculty research groups
The Lee Kong Chian School of Medicine (LKCMedicine) is a joint initiative between Imperial and Nanyang Technological University (NTU) in Singapore. Students at this brand new school pursue an innovative curriculum developed by a team within the Faculty - studying and training in a wide range of clinical settings, refining their skills through state-of-the-art simulations and accessing novel e-Learning materials through their iPad anywhere, any time. On completion of the course, students will be awarded a Bachelor of Medicine Bachelor of Surgery (MBBS) jointly by Imperial and NTU.
Lee Kong Chian School of Medicine - London Office
Learn more about Faculty courses and e-Learning in Study
Imanova, ICTEM, EIT Health
Imanova Ltd is a pioneering public-private collaboration formed by the Medical Research Council, Kings College London, University College London and Imperial. Providing both PET and MRI scanning within the same centre, Imanova acts as a major resource for imaging in the UK, allowing researchers to image not only the activity of a medicine in the body, but also to view its effect on the body systems being studied. The centre provides expertise in key techniques, preparation of radiophamaceuticals and support for clinical trials and drug development. Investigators can use the facility to evaluate at an early stage if an investigational medicine is working, and avoid unnecessary further development if products aren't effective.
Learn more about research facilities on Facilities and services page
The £73 million Imperial Centre for Translational and Experimental Medicine (ICTEM) lies adjacent to both the hospital and other major academic facilities at Imperial's Hammersmith campus. The building combines laboratory space for up to 450 scientists (spanning cardiology, cancer, genomic and metabolic research) with a state-of-the-art unit for evaluating and developing new treatments through clinical trials - the NIHR/Wellcome Trust Imperial Clinical Research Facility (CRF). The Centre was built by Imperial with support from the British Heart Foundation, Imperial College Healthcare NHS Trust, the Medical Research Council and Wellcome Trust. A major award from the National Institute for Health Research (NIHR) continues to support work within the CRF.
Imperial College London News release
The new pan-european consortium EIT Health was designated as an EU Knowledge Innovation Community (KIC) in 2014. Imperial acts as the UK and Ireland node lead for this major, Europe-wide programme. Other UK and Ireland node partners include Oxford and Cambridge, as well as major companies such as Procter & Gamble, Intel, Medtronic and AstraZeneca. One of the largest public funded initiatives for health worldwide, the EIT will invest tens of millions annually to fund new collaborations, education and projects over an initial seven year period. EIT Health will contribute to increasing the competitiveness of European industry, the sustainability of healthcare systems and will ultimately improve quality of life for the European population.
Imperial College London press release